Menlo Ventures
Greg is a partner at Menlo Ventures, where he invests in teams trying to solve major problems in life science and healthcare, with a special interest in novel therapeutic platforms, patient-focused digital health, and transformative technologies. Since joining Menlo in 2017, Greg has led investments in Clear Labs, Delfi Diagnostics, Encoded Therapeutics, Epiodyne, Pliant Therapeutics, Senti Biosciences, and Vital Labs.
This person is not in any offices
Menlo Ventures
12 followers
Menlo pursues companies with the potential to disrupt huge markets and invests primarily in early-stage consumer, enterprise, and life science technologies.